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Arjunāriṣṭa is commonly used oral liquid cardiotonic prepared using Terminalia arjuna as an active constituent. It nourishes and strengthens heart muscles and promotes cardiac functioning by regulating blood pressure and cholesterol. [12] Ayurvedic products available in the market vary in quality and therapeutic efficacy due to the differences in composition of the products. Knowledge about active principles of herbal preparations are not well defined, information on toxicity and adverse effects of these formulations are lacking. Quality is the paramount issue because it can affect the efficacy and/ or safety of the products being used. In the traditional fermented formulation of arjunāriṣṭa, the period required for fermentation is around 25 days. Dhātakī and Mahua flowers contain microorganisms which are responsible for fermentation along with other microorganisms which may adversely affect the quality of the formulations. In the present study attempt has been made for formulation of arjunāriṣṭa by a modern method and its quality is assessed.
Methodology

Collection of plant material
Plant materials Terminalia arjuna (Combretaceae) bark, flowers of Madhuca indica (Sapotaceae) and Woodfordia fruticose (Lythraceae) were collected from forests of Sahyadri Ghats of Maharashtra (India); fruits of Vitis venifera (Venifera) and jaggery were procured from local market.
Instruments
Calibrated digital pH (HANNA) was used to check the pH of the formulation. Viscosity of formulations was determined with the help of Ostwald Viscometer. The refractive index of formulations was determined using Abbe's Refractometer. HPTLC (Anchrome Mumbai) was used for quantitative analysis of the formulation and Gallic acid.
Isolation of microorganisms
Microorganisms (MO) were isolated from Woodfordia fruticosa (Dhātakī) flowers using a streak plate technique. [13] Sabouraud dextrose agar medium was used for isolation of microorganisms. pH of this agar medium was adjusted to 5.6 ± 0.2 using acid or base. [14] Isolated microorganisms were stored on Sabouraud dextrose agar slant at 4°C. Suspension of these micro organisms in sterile water were prepared and transferred aseptically in each flask for fermentation. Numbers of cells present in suspension were counted using Neubars chamber. A cell count of 4.6 × 10 7 cells ml -1 was adjusted by suitable dilution.
Preparation of formulation
Traditional method
Pulverized Terminalia arjuna bark was passed through sieve no. 44. Required quantity of powder was taken in a flask and soaked in distilled water overnight. Decoction of Arjuna powder was prepared, by heating till only one fourth of volume of the water remained. It was then filtered and jaggery was added in required amount and dissolved completely. Dhātakī flowers, Mahua flowers, drākṣā in required quantity were taken, properly cleaned and then added to the flask. After addition of the ingredients the flask was tightly closed with a cotton plug and kept in a dark room for 25 days for fermentation. It was then opened and the contents were filtered through a muslin cloth. Filtrate was collected in a container and evaluated for different parameters. [15] Using similar method, Formulation A was prepared with all ingredients, namely Arjuna bark powder, Dhātakī flower, Mahua flower, Drākṣā, jaggery and water. Similarly, formulation C and formulation E were prepared, excluding Mahua and Dhātakī flowers respectively [ Table 1 ].
New method of Arjunāriṣṭa preparation
Arjunāriṣṭa is a fermented liquid preparation made with ingredients in the composition shown in Table 1 . Pulverized Terminalia arjuna bark was passed through sieve no. 44. Required quantity of powder was taken in a flask and soaked in distilled water overnight. Decoction of Arjuna powder was prepared boiling the solution to one fourth the initial volume. It was then filtered, Jaggery and Drākṣā were added in required amount and dissolved completely. Woodfordia fruticosa (Dhātakī) and Mahua flowers were added. Autoclaving of the flask was done at 121°C for 20 minutes. 1 ml suspensions of microorganisms isolated from the flowers were then added aseptically in flask which was sealed thereafter with cotton plug and parafilm sealing. These flasks were kept at constant temperature in the incubator at 37 ± 0.5°C for 20 days. After 20 days these flasks were opened, content filtered through Muslin cloth and the filtrate was used for further evaluation studies. Using this procedure formulation B was prepared with all ingredients, namely Arjuna bark powder, Dhātakī flower, Mahua flower, Drākṣā, Jaggery, Water and suspension (isolated microorganism from dhātakī flowers). Formulation D was prepared with the ingredients, namely Arjuna bark powder, Dhātakī flower, Drākṣā, Jaggery, Water and 
Physico-chemical analysis of Arjunāriṣṭa
Physico-chemical analysis was done to ascertain the quality of the formulation. The parameters as mentioned in "Quality Standards of Indian Medicinal Plants" by Indian Council of Medical Research were followed to check the quality of the prepared formulations. [16] Determination of organoleptic characteristics viz. odor, taste, color, clarity, pH, viscosity and refractive index of the prepared formulation of Arjunāriṣṭa was carried out. Using a calibrated pH meter the pH of the formulations was analyzed for 14 days to evaluate acidity of formulation and to study the effect of the environmental conditions on pH. Generally, the formulations having less alcohol content have higher pH. Viscosity of the Arjunāriṣṭa formulation was determined with the help of Brookfield Viscometer. The refractive index of the prepared formulations was determined by using Abbe's refractometer.
Quantitative analysis of formulations
Determination of acid value 5g of formulation was dissolved in 25 ml of equal volume of ethanol and ether previously neutralized with 0.1 M KOH to phenolphthalein solution. To it, 1ml of phenolphthalein solution was added and titrated with 0.1 M KOH until the solution remained faint pink after shaking for 30 sec. [11] Determination of alcohol content by distillation method Not less than 25 ml of preparation was transferred to the distillation flask and its temperature was noted. It was diluted with equal volume of water. It was then subjected to distillation and the distillate about 2 ml less than the total volume was collected. Water was added to make up to the same volume of original test liquid and adjusted to the temperature noted before. The specific gravity of this liquid was determined and alcohol content analyzed using relative density table given in the United States Pharmacopoeia (USP). [17] Determination of alcohol content by dichromate oxidation method 10 ml of formulation was taken and 15 ml of water was added to it and subjected to distillation to obtain 20 ml of distillate. Then 5 ml of water was added to it. 0.5 ml volume was then taken from it and 2 ml water along with 2.5 ml potassium dichromate solution were added. Absorbance of the resulting solution was measured at 590 nm. The calibration curve of alcohol determination was plotted similarly by using known concentration of ethanol as (1% to 8% v/v) From the equation of calibration curve the alcohol content of all formulations was determined. [18] Total solid content An evaporating dish which was previously weighed was taken and 10 g of formulation was allowed to evaporate so that only solid content remains in the dish and the rest of the fluid gets evaporated. Then it was reweighed and the solid content of formulation was calculated. [15] Total phenolic content Absorbance of standard tannic acid solutions are recorded on UV-visible spectrophotometer (Shimadzu-1800) at 750 nm and the standard curve was plotted. Sample of Arjunāriṣṭa prepared as per Ayurvedic Pharmacopoeia of India and processed for estimation of total phenolic content. [19] Analysis of Arjunāriṣṭa by TLC method 
Analysis of arjunāriṣṭa by high performance thin layer chromatography
HPTLC method was used to develop a standard procedure for the qualitative and quantitative evaluation of Arjunāriṣṭa formulations. Quantitative determination was carried out using Gallic acid as reference standard.
Preparation of standard gallic acid
1 mg of Gallic acid was accurately weighed and dissolved in methanol and final volume made up to 10 ml.
Preparation of sample of Arjunāriṣṭa
5 ml of formulation was taken in a petri dish and evaporated in vacuum oven at 65°C with applied vacuum 15 mm Hg. Subsequent washing using 7 ml methanol was done. This solution was filtered through 0.2 micron size filter and used for further analysis.
Standardization of standard gallic acid and Arjunāriṣṭa formulation
Carnage HPTLC 8 system comprising of Linomat 5 as sample applicator and TLC Scanner 3 controlled by WinCATS software version 1.3.4 was used for quantitative evaluation. Stationary phase used was MERCK precoated TLC Aluminium silica gel 60 F254 plates and the mobile phase used was toluene: ethyl acetate: formic acid (5:5:1). Samples and standard were applied as 8 mm bands with 10 mm distance between the tracks. Tank saturation and plate equilibrium were carried with filter paper for 10 min.
Ascending development for a distance of 80 mm in a twin trough chamber was completed in approximately 15 min. Volume of the standard was first optimized at 5 μl for fingerprinting. The volume of the sample was optimized to 5 μl for quantification. It was then simultaneously applied with different concentration of standard Gallic acid. [20] Results
Physicochemical evaluation
Color, odor, taste, pH, viscosity and refractive index of all formulations were determined. pH of all formulations were found to be in the range of 3.70 ± 0.03 to 5.17 ± 0.02 [ Table 2 ]. The viscosities of formulations were found to be 1.44 ± 0.12 to 2.93 ± 0.04 cps, shown in Table 2 . The range of refractive index of formulations was found to be 1.381 to 1.395, the results are shown in Table 2 .
Quantitative analysis of formulation
Acid value
The acid value of all formulations was found to be in the range of 1.04 ± 0.02 to 1.26 ± 0.04 as shown in Table 3 .
Determination of alcohol content
The alcohol content was determined by distillation method and dichromate technique. By distillation method -Formulation B showed a maximum (5.98 ± 0.05% v/v) and formulation E possessed a minimum (2.96 ± 0.31% v/v) alcohol [ Table 3 ]. As per Ayurvedic Pharmacopoeia of India the limit of alcohol content for Arjunāriṣṭa is in the range 5 to 12% v/v [15] . By Dichromate oxidation method -Formulation B showed a maximum (5.82 ± 0.09% v/v) and formulation E showed (2.79 ± 0.34% v/v) alcohol [ Table 3 ].
Total solid content
Total solid content has moderate impact over viscosity. Increase in solid content increases viscosity. All evaluated formulations possessed total solid content of 10.11 ± 0.17 to 12.45 ± 0.27% w/v. Among these formulations F showed maximum and formulation A the minimum total solid content [ Table 3 ].
Quantitative determination of phenol content by Folin-ciocalteau method
Total phenol content has an impact over the pH of the formulation. pH and total phenol content are inversely related to each other. [19] Among all the evaluated formulations, Formulation B had maximum total phenol content of (0.11 ± 0.01% w/v) and Formulation C showed a minimum total phenol content of (0.08 ± 0.00% w/v). Results are shown in Table 3 . 
Analysis of formulations and gallic acid (Standard) by TLC method
Estimation of gallic acid in formulations A, B, C, D, E and F by HPTLC
Gallic acid was found to be 0.0227, 0.0277, 0.0110, 0.0207, 0.00538 and 0.00834% w/v in Formulations A, B, C, D, E and F respectively. HPTLC chromatogram of standard Gallic acid is shown in Figure 2a . The suitability 
Discussion
It may be suggested that Brewer's yeast-induced fermentation, as employed by many manufacturers of Ayurvedic medicines to reduce production costs, is no substitute for the traditional fermentation described in the ancient Ayurvedic literature. Such practices may not produce authentic fermented Ayurvedic medicines. [21] Fermentation processes help in rupturing the cells of the herbs and exposing their contents to biotransformation. It also creates an active transport system with dissolved constituents from the herbal material to the solvent. [22] In the traditional technique of preparation of Arjunāriṣṭa, there are issues related to safety, quality and efficacy of the product due to different plant materials obtained from different sources. The flowers which are responsible for fermentation vary in number of microorganisms which are responsible for fermentation and thus affect alcohol production. Also, earthen pot containing all ingredients is buried underground (21-25 days) for the fermentation process, therefore uniform temperature is not maintained which adversely affects the fermentation process. As indicated in available literature, marketed formulations of Arjunāriṣṭa, have brand to brand variation in content and therefore, action. Hence, reproducibility of the results is the prime issue in the manufacture of Ayurvedic formulations.
To overcome the aforesaid problem, an attempt has been made to employ a modern technique to use isolated microorganisms from the Woodfordia fruticosa (Dhātakī) flower which are responsible for fermentation. These isolated microbes were introduced into the mixture containing ingredients of Arjunāriṣṭa and further kept in an incubator at 37°C. The number of days required for fermentation were reduced from 25 to 20 days. The fixed amount of suspension of microorganism was found to generate approximately the same amount of alcohol which causes extraction of active constituents from Arjuna bark and also act as a preservative.
In the present approach, the basic principles of Ayurveda with regard to the preparation method remain the same. But with an improvement in the quality, safety and efficacy of the product. The alcohol content was determined by distillation method and dichromate technique.
We have prepared three formulations (formulation A, C and E) to assess the effect of flowers Woodfordia fruticosa (Dhātakī) and Mahua on traditional fermentation process. It was found that microorganisms from Woodfordia fruticosa (Dhātakī) flower have a major role to play in the fermentation process. Three formulations were prepared by modern technique (formulation B, D and F). It does not show marked variation in alcohol production. HPTLC study revealed that gallic acid content in the formulations was in the range of 0.01-0.02.
Woodfordia fruticosa (Dhātakī) and Mahua flowers have a number of essential constituents which contain different antioxidant compounds required for its action. Therefore, they were included in the present method of preparation to be true to the basic principles of Ayurveda. 
Conclusion
Scientific explorations in the area of Ayurvedic drug manufacturing along with customization of present technologies to be true to the principles of Ayurveda would greatly facilitate standardization of drug manufacture. In the present study, we have tried to implement current evidence based knowledge for modernization of a traditional Ariṣṭa formulation.
One of the characteristics of Ayurvedic herbal medicinal preparations is that single herbs or as collections of herbs in composite formulae and are extracted using boiling water during the decoction process. This may be the main reason why quality control of such herbal drugs is more difficult than that of biomedicines. Fermentation period as per traditional method is around 25 days. By adopting the proposed modern technique this period was reduced to 20 days without compromising with the quality of the product. A defined procedure for fermented formulation, will ensure reproducibility and facilitate easier quality assessment. Preparation of Ariṣṭa by using isolated microorganisms on the basis of their fermenting capabilities can help generate approximately same quantities of alcohol in formulation. Formulations prepared by using modern techniques (Formulation B, D and F) were found to contain approximately same quantity of self generated alcohol as compared to formulations prepared by traditional methods (Formulation A, C and E), which may be attributed to use of isolated microorganism from Dhātakī flowers. This method can also ensure prevention of the growth of unwanted microbes. It may lead to an extraction to the same extent in all batches and will improve the efficacy and safety of the product.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Introduction
Anaemia is a major global public health problem with consequences on human health, social and economical development. Anaemia can be caused due to multiple factors but one of the major factors is nutritional deficiency. IDA is the most significant contributor of all anaemias and hence IDA and anaemia are often used synonymously. Around 30-52% of nonindustrialized population has anaemia in general and iron deficiency in particular. [1] Iron deficiency and IDA were considered as one among the top 10 risks globally and regionally, [2] contributing to the 14 th leading cause of disease burden in the world global burden of diseases. [3] IDA causes 8.4 lakh deaths and 35 million cases of disability adjusted life years (DALYs). [4] In India, surveys have shown high prevalence of anaemia. [5] Anaemia prevalence was 56.2 percent in women
Abstract
Background: This paper explores the role that Ayurveda can play in the management of Iron Deficiency Anaemia, a major nutritional deficiency disorder affecting people across the globe. Methodology: Forty (40) patients suffering from Iron deficiency anaemia as per WHO guidelines, between the age group of 20 to 60 yrs of either sex participated in the study. Study was a randomized, controlled, open label clinical study. Patients were randomly divided into two groups: Group D (n = 20) received Dhātrī avaleha 10 g twice a day after food. Group K (n = 20) received capsules Kasīsa bhasma 125 mg thrice a day. Both interventions were administered for 30 days and the subjects were followed up for next 30 days with placebo capsules to assess the sustainability of the effects. Assessments were done at baseline, 30 th and 60 th days. Primary outcome measure was hemoglobin estimation (Hb) and secondary outcome measures were the other hematological parameters such as Red blood cell (RBC) indices, total RBC count, Packed Cell volume (PCV) and Peripheral Blood smear study. Results: Both interventions produced significant improvements (P < 0.001). Kasīsa bhasma was better compared to dhātrī avaleha in terms of primary (P < 0.0001) and secondary outcomes. Comparison of outcomes from base line -30 th day, base line -60 th day and 30 th -60 th day showed significant (P < 0.0001) improvement in both the groups in parameters such as haemoglobin, MCV and MCH. Hence improvements sustained during placebo intervened sustainability period also. Conclusions: Study effectively shows that Kasīsa bhasma is better then Dhātrī avaleha. Improvements by both interventions were sustained even during the sustainability period. of 15-49 yrs of age, 79.2 percent among children aged 6-35 months, 57.9 percent in pregnant women and 24.3 percent in men aged 15-49 yr. Sex prevalence shows that 55% of women and 25% of men suffer from anaemia. [6] It has been estimated that iron deficiency costs India about 5 percent of its gross national product (GNP) annually from loss of lives, resources and productivity. [7] The main reasons for IDA have been determined to be inadequate intake of iron, low bioavailability of dietary iron from plant foods due to inhibitory factors, low levels of absorption enhancers in the diet, repeated pregnancies, increased needs during growth and development among children and adolescents, parasitic infestations and chronic blood loss. Poverty compounds these factors through inadequate access to dietary diversity, safe water, knowledge about safe food handling and proper feeding practices. [8] Anaemia and iron deficiency is known to have several functional consequences. IDA adversely effects cognitive performance, behavior, physical growth in children. IDA during pregnancy increases the perinatal risks of mother and infant. Overall increase in infant mortality, decreased functioning of immune system, reduced work capacity and productivity, endocrine and neurotransmitter abnormality associated with triiodothyronine, thyroid function general, production and metabolism of catecholamines. increased risk of heavy metal absorption. [9] Preventive strategies are through food based approaches that cause multi nutritional benefit. Foods rich in iron such as meat, organs of cattle, fish, poultry, legumes and green leafy vegetables are beneficial. Enhancers of Iron absorption such as haem iron of animal origin, ascorbic acid or Vitamin C and inhibitors of Iron absorption like phytates of cereal grains, legumes, nuts, seeds, iron-binding phenolic compounds (tannins) in tea, coffee, calcium of milk and milk products play a determining role. Conventional approach for IDA is through Iron Supplements such as ferrous sulphate etc., However, adherence to the medication is difficult due to various side effects such as epigastric discomfort, nausea, diarrhoea, or constipation. [1] Side effects can be minimized by drug intake along with food, however, doing this reduces the iron absorption by 40%. [10] Iron preparations inhibit the absorption of other drugs such as tetracyclines, sulphonamides, and trimethoprim. [1] Hence there is a need to look for newer agents which have a better therapeutic utility.
Complementary and alternative systems (CAM) or traditional Medicines (TM) which are widely used by the ailing community needs to be explored. In countries such as Republic of Korea and China, in spite of well established conventional health care 86% and 90% of population commonly use TM. [11] Ayurveda has analysed the different types of anemia under the classification of Pandu roga. [12] Ayurveda has indicated use of various herbal formulations like dhātrī avaleha [13] and iron formulations such as Loha bhasma, Maṇḍura bhasma, Mākṣika bhasma, Gairika, Vimala and Kasīsa [14] for this ailment. Hence the present study was designed with an objective to evaluate effect of a noniron formulation, Dhātrī avaleha with an iron formulation Kasīsa bhasma in patients of IDA. The study was also aimed to evaluate the sustainability effect of the drugs.
Methodology
Aims and objective
To evaluate the effect of Dhātrī avaleha in patients of Iron Deficiency Anaemia.
The null hypothesis states that there is no difference in clinical outcome of Dhātrī avaleha on IDA when compared to the standard drug kasīsa bhasma.
Patients attending outpatient department of the institute were recruited for the study. The CONSORT statement guidelines has been followed in reporting the outcomes of the study. [15] 
Screening measures
All the patients were thoroughly screened for Iron deficiency anaemia. Assessments of patients were through an extensive clinical examinations and on Ayurvedic parameters such as prakṛti and other laboratory parameters.
The following laboratory investigations were carried out at Clinical Laboratory, SDM Ayurveda Hospital Udupi in all patients at baseline, 30 th and 60 th days of intervention: Blood investigation-Haemoglobin concentration, Total RBC count, Total Leukocyte count, Differential Leukocyte count, Peripheral Blood smear study, Haematocrit (PCV) and Stool examination for ova and cysts. In addition to the above, we conducted other investigations such as Clotting Time, Bleeding Time, Liver Function Test, Renal Function Test, Sonography of abdomen etc., as and when required to rule out co morbidities.
Research design
The present study is a randomized, controlled, open label, parallel group comparative clinical study. The scholars involved in randomization, distribution and administration of study articles were independent from the investigators. Computer generated random numbers were utilized for the study. Block size was 4. During study, patients were asked to adhere to the treatment protocol and report any adverse events to the investigators at the earliest. Any clinical manifestation that was likely to cause considerable distress was screened for possible adverse events. All patients were subjected to dīpana-pācana (increasing the metabolic activity) and koṣṭha śodhana (cleansing of gut using mild laxatives) procedures, which is a standard preparatory procedure [17] in Ayurveda before starting any medication. Dīpana -pācana was done using Pañcakola ciūrnִ a [18] 5 g three times a day, before meals, for 3-7 days with hot water, till the desired manifestations such as lightness of body, proper evacuation of flatus, urine, feces, feeling of purity in heart, eructation, feeling of normalcy and purity in throat and mouth, disappearance of drowsiness and exertion, appetite for food [19] were observed in the patient. Koṣṭha śuddhi (cleansing of gut) was done with administration of śuddhi cūrṇa [20] 5 g at bed time, with water. Later, all patients were randomized into two groups through block randomization procedure. Patients in Group D received Dhātrī avaleha 10 g twice a day after food with water. Patients in Group K received Kasīsa bhasma capsules 125 mgs, thrice a day, after food, with water. Dhātrī avaleha [21] and Kasīsa bhasma dosages [22] were as per the classical literature. Ingredients of the formulations were procured from authentic distributors and formulations were prepared in GMP approved SDM Ayurveda Pharmacy Udupi as per the standard procedures. Total duration of study was for 2 months in which interventions with Ayurveda medication was for one month. For an additional one month, observations were maintained with a starch placebo capsules of 250 mg thrice a day. Assessments were done at baseline, 30 th day and 60 th day of interventions [ Figure 1 ]. The nature and design of the study were explained to patients, and informed consent was obtained. 
Assessments
Statistical methods
Statistical analysis was carried out using SPSS Version 15.0. Homogeneity of the data across the groups was evaluated by the χ 2 test. Comparison of groups across different time points was carried out by repeated-measure analysis of variance (ANOVA) with Tukey post-hoc test.
Comparison of groups at baseline was by one-way ANOVA with Tukey posthoc test. Effect size was calculated by Partial Eta Square method to assess the effect of treatment through the outcome from baseline to 30 th and 60 th day of treatment. The criteria used for interpreting effect size measures were as follows: 0-0.2 = minimal, 0.2-0.5 = small, 0.5-0.8 = medium and above 0.8 = large effect size.
[23] Values are reported as mean ± 1 standard deviation. All tests were considered statistically significant at P < 0.05.
Results
A total of 40 patients were recruited and divided in to two groups. One patient from Group D and two patients from group K dropped out from the study. Drop outs were due to their illnesses such as typhoid needing other medications. In one case it was due to the patient having shifted to a different place. No adverse effects were reported in any of the patients [ Figure 1 ].
Subject characteristics
Most of the patients in our study were young (28.24 ± 7.53 yrs), females (62.5%), married (65%), from rural area (65%), high school educated (37.5%), lower middle class (47.5%), mixed diet (67.5%), body constitution of vāta pittaja prakṛti (60%), duration of current manifestations (7.6 ± 5.93 months) [ Table 1 ].
Primary out come-hemoglobin
Repeated measure ANOVA with time as within subject factor and groups as between subject factor showed a significant effect of time F(2,70) =217.130, P < 0.001. Both groups showed significant improvement that sustained during the course of the treatment. There was a significant effect of group F(1, 35) =37.583, P < 0.001 or group X time interaction F(2, 70) =11.233, P < 0.001. Post hoc analysis revealed at the end of 30 days and 60 days group K showed significant improvement (P < 0.0001) compared to group D [Table 2a and Figure 2 ]. 
